GB201209670D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB201209670D0
GB201209670D0 GBGB1209670.7A GB201209670A GB201209670D0 GB 201209670 D0 GB201209670 D0 GB 201209670D0 GB 201209670 A GB201209670 A GB 201209670A GB 201209670 D0 GB201209670 D0 GB 201209670D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1209670.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Convergence Pharmaceuticals Ltd
Original Assignee
Convergence Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Convergence Pharmaceuticals Ltd filed Critical Convergence Pharmaceuticals Ltd
Priority to GBGB1209670.7A priority Critical patent/GB201209670D0/en
Publication of GB201209670D0 publication Critical patent/GB201209670D0/en
Priority to PCT/GB2013/051446 priority patent/WO2013179049A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1209670.7A 2012-05-31 2012-05-31 Novel compounds Ceased GB201209670D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1209670.7A GB201209670D0 (en) 2012-05-31 2012-05-31 Novel compounds
PCT/GB2013/051446 WO2013179049A1 (en) 2012-05-31 2013-05-31 Spiro derivatives as voltage - gated sodium channel modulators

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1209670.7A GB201209670D0 (en) 2012-05-31 2012-05-31 Novel compounds

Publications (1)

Publication Number Publication Date
GB201209670D0 true GB201209670D0 (en) 2012-07-18

Family

ID=46582109

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1209670.7A Ceased GB201209670D0 (en) 2012-05-31 2012-05-31 Novel compounds

Country Status (2)

Country Link
GB (1) GB201209670D0 (en)
WO (1) WO2013179049A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201209015D0 (en) 2012-05-22 2012-07-04 Convergence Pharmaceuticals Novel compounds
SG11202002707VA (en) 2017-10-10 2020-04-29 Biogen Inc Process for preparing spiro derivatives
JP7268049B2 (en) 2018-03-08 2023-05-02 インサイト・コーポレイション Aminopyrazinediol compounds as PI3K-γ inhibitors
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200728258A (en) * 2005-10-10 2007-08-01 Glaxo Group Ltd Novel compounds
GB0706630D0 (en) * 2007-04-04 2007-05-16 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
WO2013179049A1 (en) 2013-12-05

Similar Documents

Publication Publication Date Title
HK1201819A1 (en) Novel compounds
GB201207406D0 (en) Novel compounds
HK1212985A1 (en) Novel compounds
EP2922550A4 (en) Novel compounds
HK1208826A1 (en) Novel compounds
GB201212871D0 (en) Novel compounds
EP2922547A4 (en) Novel compounds
IL280595A (en) Novel compounds
GB201209986D0 (en) Novel compounds
GB201222711D0 (en) Novel compounds
GB201207392D0 (en) Novel compounds
GB201209670D0 (en) Novel compounds
GB201212816D0 (en) Novel compounds
GB201222419D0 (en) Novel compounds
GB201222433D0 (en) Novel compounds
GB201222435D0 (en) Novel compounds
GB201222430D0 (en) Novel compounds
GB201222393D0 (en) Novel compounds
GB201219554D0 (en) Novel compounds
GB201219472D0 (en) Novel compounds
GB201217387D0 (en) Novel compounds
GB201216548D0 (en) Novel compounds
GB201216551D0 (en) Novel compounds
GB201213023D0 (en) Novel compounds
GB201211246D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)